This report aims to provide a comprehensive presentation of the global market for Gastroesophageal Reflux Disease (GERD) Drugs and Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastroesophageal Reflux Disease (GERD) Drugs and Devices. This report contains market size and forecasts of Gastroesophageal Reflux Disease (GERD) Drugs and Devices in global, including the following market information:
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Medication Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gastroesophageal Reflux Disease (GERD) Drugs and Devices include AstraZeneca, Plc., Addex Therapeutics, Takeda Pharmaceutical Company Limited, Rottapharm (Meda AB), Pfizer, Inc., Eisai Co. Ltd., The Procter & Gamble Company, Mederi Therapeutics and Aros Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gastroesophageal Reflux Disease (GERD) Drugs and Devices companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Segment Percentages, by Type, 2022 (%)
- Medication
- Minimally Invasive Surgery
- Invasive Surgery
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Segment Percentages, by Application, 2022 (%)
- Heartburn
- Acid reflux disorders
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Gastroesophageal Reflux Disease (GERD) Drugs and Devices revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Gastroesophageal Reflux Disease (GERD) Drugs and Devices revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca, Plc.
- Addex Therapeutics
- Takeda Pharmaceutical Company Limited
- Rottapharm (Meda AB)
- Pfizer, Inc.
- Eisai Co. Ltd.
- The Procter & Gamble Company
- Mederi Therapeutics
- Aros Pharma
- Torax Medical, Inc.
- BD
- EndoGastric Solutions
- Medigus Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gastroesophageal Reflux Disease (GERD) Drugs and Devices, market overview.
Chapter 2: Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market size in revenue.
Chapter 3: Detailed analysis of Gastroesophageal Reflux Disease (GERD) Drugs and Devices company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gastroesophageal Reflux Disease (GERD) Drugs and Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Overall Market Size
2.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size: 2022 VS 2029
2.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players in Global Market
3.2 Top Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Companies Ranked by Revenue
3.3 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Companies
3.4 Top 3 and Top 5 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Companies in Global Market, by Revenue in 2022
3.5 Global Companies Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players in Global Market
3.6.1 List of Global Tier 1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Companies
3.6.2 List of Global Tier 2 and Tier 3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Markets, 2022 & 2029
4.1.2 Medication
4.1.3 Minimally Invasive Surgery
4.1.4 Invasive Surgery
4.2 By Type - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue & Forecasts
4.2.1 By Type - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, 2018-2023
4.2.2 By Type - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, 2024-2029
4.2.3 By Type - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2022 & 2029
5.1.2 Heartburn
5.1.3 Acid reflux disorders
5.2 By Application - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue & Forecasts
5.2.1 By Application - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, 2018-2023
5.2.2 By Application - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, 2024-2029
5.2.3 By Application - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2022 & 2029
6.2 By Region - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue & Forecasts
6.2.1 By Region - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, 2018-2023
6.2.2 By Region - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, 2024-2029
6.2.3 By Region - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, 2018-2029
6.3.2 US Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2018-2029
6.3.3 Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2018-2029
6.3.4 Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, 2018-2029
6.4.2 Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2018-2029
6.4.3 France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2018-2029
6.4.4 U.K. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2018-2029
6.4.5 Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2018-2029
6.4.6 Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2018-2029
6.4.7 Nordic Countries Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2018-2029
6.4.8 Benelux Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, 2018-2029
6.5.2 China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2018-2029
6.5.3 Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2018-2029
6.5.4 South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2018-2029
6.5.5 Southeast Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2018-2029
6.5.6 India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, 2018-2029
6.6.2 Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2018-2029
6.6.3 Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, 2018-2029
6.7.2 Turkey Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2018-2029
6.7.3 Israel Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2018-2029
6.7.4 Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2018-2029
6.7.5 UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2018-2029
7 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Companies Profiles
7.1 AstraZeneca, Plc.
7.1.1 AstraZeneca, Plc. Company Summary
7.1.2 AstraZeneca, Plc. Business Overview
7.1.3 AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
7.1.4 AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global Market (2018-2023)
7.1.5 AstraZeneca, Plc. Key News & Latest Developments
7.2 Addex Therapeutics
7.2.1 Addex Therapeutics Company Summary
7.2.2 Addex Therapeutics Business Overview
7.2.3 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
7.2.4 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global Market (2018-2023)
7.2.5 Addex Therapeutics Key News & Latest Developments
7.3 Takeda Pharmaceutical Company Limited
7.3.1 Takeda Pharmaceutical Company Limited Company Summary
7.3.2 Takeda Pharmaceutical Company Limited Business Overview
7.3.3 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
7.3.4 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global Market (2018-2023)
7.3.5 Takeda Pharmaceutical Company Limited Key News & Latest Developments
7.4 Rottapharm (Meda AB)
7.4.1 Rottapharm (Meda AB) Company Summary
7.4.2 Rottapharm (Meda AB) Business Overview
7.4.3 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
7.4.4 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global Market (2018-2023)
7.4.5 Rottapharm (Meda AB) Key News & Latest Developments
7.5 Pfizer, Inc.
7.5.1 Pfizer, Inc. Company Summary
7.5.2 Pfizer, Inc. Business Overview
7.5.3 Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
7.5.4 Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global Market (2018-2023)
7.5.5 Pfizer, Inc. Key News & Latest Developments
7.6 Eisai Co. Ltd.
7.6.1 Eisai Co. Ltd. Company Summary
7.6.2 Eisai Co. Ltd. Business Overview
7.6.3 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
7.6.4 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global Market (2018-2023)
7.6.5 Eisai Co. Ltd. Key News & Latest Developments
7.7 The Procter & Gamble Company
7.7.1 The Procter & Gamble Company Company Summary
7.7.2 The Procter & Gamble Company Business Overview
7.7.3 The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
7.7.4 The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global Market (2018-2023)
7.7.5 The Procter & Gamble Company Key News & Latest Developments
7.8 Mederi Therapeutics
7.8.1 Mederi Therapeutics Company Summary
7.8.2 Mederi Therapeutics Business Overview
7.8.3 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
7.8.4 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global Market (2018-2023)
7.8.5 Mederi Therapeutics Key News & Latest Developments
7.9 Aros Pharma
7.9.1 Aros Pharma Company Summary
7.9.2 Aros Pharma Business Overview
7.9.3 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
7.9.4 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global Market (2018-2023)
7.9.5 Aros Pharma Key News & Latest Developments
7.10 Torax Medical, Inc.
7.10.1 Torax Medical, Inc. Company Summary
7.10.2 Torax Medical, Inc. Business Overview
7.10.3 Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
7.10.4 Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global Market (2018-2023)
7.10.5 Torax Medical, Inc. Key News & Latest Developments
7.11 BD
7.11.1 BD Company Summary
7.11.2 BD Business Overview
7.11.3 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
7.11.4 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global Market (2018-2023)
7.11.5 BD Key News & Latest Developments
7.12 EndoGastric Solutions
7.12.1 EndoGastric Solutions Company Summary
7.12.2 EndoGastric Solutions Business Overview
7.12.3 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
7.12.4 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global Market (2018-2023)
7.12.5 EndoGastric Solutions Key News & Latest Developments
7.13 Medigus Ltd.
7.13.1 Medigus Ltd. Company Summary
7.13.2 Medigus Ltd. Business Overview
7.13.3 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
7.13.4 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global Market (2018-2023)
7.13.5 Medigus Ltd. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Opportunities & Trends in Global Market
Table 2. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Drivers in Global Market
Table 3. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Restraints in Global Market
Table 4. Key Players of Gastroesophageal Reflux Disease (GERD) Drugs and Devices in Global Market
Table 5. Top Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Share by Companies, 2018-2023
Table 8. Global Companies Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Type
Table 9. List of Global Tier 1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2024-2029
Table 30. AstraZeneca, Plc. Company Summary
Table 31. AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 32. AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn) & (2018-2023)
Table 33. AstraZeneca, Plc. Key News & Latest Developments
Table 34. Addex Therapeutics Company Summary
Table 35. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 36. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn) & (2018-2023)
Table 37. Addex Therapeutics Key News & Latest Developments
Table 38. Takeda Pharmaceutical Company Limited Company Summary
Table 39. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 40. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn) & (2018-2023)
Table 41. Takeda Pharmaceutical Company Limited Key News & Latest Developments
Table 42. Rottapharm (Meda AB) Company Summary
Table 43. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 44. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn) & (2018-2023)
Table 45. Rottapharm (Meda AB) Key News & Latest Developments
Table 46. Pfizer, Inc. Company Summary
Table 47. Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 48. Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn) & (2018-2023)
Table 49. Pfizer, Inc. Key News & Latest Developments
Table 50. Eisai Co. Ltd. Company Summary
Table 51. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 52. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn) & (2018-2023)
Table 53. Eisai Co. Ltd. Key News & Latest Developments
Table 54. The Procter & Gamble Company Company Summary
Table 55. The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 56. The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn) & (2018-2023)
Table 57. The Procter & Gamble Company Key News & Latest Developments
Table 58. Mederi Therapeutics Company Summary
Table 59. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 60. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn) & (2018-2023)
Table 61. Mederi Therapeutics Key News & Latest Developments
Table 62. Aros Pharma Company Summary
Table 63. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 64. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn) & (2018-2023)
Table 65. Aros Pharma Key News & Latest Developments
Table 66. Torax Medical, Inc. Company Summary
Table 67. Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 68. Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn) & (2018-2023)
Table 69. Torax Medical, Inc. Key News & Latest Developments
Table 70. BD Company Summary
Table 71. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 72. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn) & (2018-2023)
Table 73. BD Key News & Latest Developments
Table 74. EndoGastric Solutions Company Summary
Table 75. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 76. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn) & (2018-2023)
Table 77. EndoGastric Solutions Key News & Latest Developments
Table 78. Medigus Ltd. Company Summary
Table 79. Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 80. Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn) & (2018-2023)
Table 81. Medigus Ltd. Key News & Latest Developments
List of Figures
Figure 1. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Segment by Type in 2022
Figure 2. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Segment by Application in 2022
Figure 3. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in 2022
Figure 8. By Type - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share, 2018-2029
Figure 9. By Application - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share, 2018-2029
Figure 10. By Type - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share, 2018-2029
Figure 12. By Application - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share, 2018-2029
Figure 14. By Region - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share, 2018-2029
Figure 15. By Country - North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share, 2018-2029
Figure 16. US Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share, 2018-2029
Figure 20. Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2029
Figure 21. France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share, 2018-2029
Figure 28. China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2029
Figure 32. India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share, 2018-2029
Figure 34. Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share, 2018-2029
Figure 37. Turkey Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2018-2029
Figure 41. AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
